Radiotherapy with or without temozolomide in elderly patients aged >= 70 years with glioblastoma
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.20, sa.3, ss.251-255, 2016 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 20 Sayı: 3
- Basım Tarihi: 2016
- Doi Numarası: 10.5114/wo.2016.61569
- Dergi Adı: WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
- Sayfa Sayıları: ss.251-255
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Eskişehir Osmangazi Üniversitesi Adresli: Evet
Özet
Introduction: Although the recommended optimal treatment of glioblastoma multiforme (GBM) is adjuvant chemoradiotherapy, trials in GBM have excluded patients older than 70 years. In this study, we aimed to assess overall survival (OS) and prognostic factors in elderly patients (>= 70 years) with newly diagnosed GBM treated with radiotherapy (RT) +/- concurrent/adjuvant temozolomide (TMZ).